These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 20409374)

  • 1. Multihospital outbreak of Clostridium difficile infection, Cleveland, Ohio, USA.
    Jump RL; Riggs MM; Sethi AK; Pultz MJ; Ellis-Reid T; Riebel W; Gerding DN; Salata RA; Donskey CJ
    Emerg Infect Dis; 2010 May; 16(5):827-9. PubMed ID: 20409374
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Elevated levels of intestinal inflammation in Clostridium difficile infection associated with fluoroquinolone-resistant C. difficile.
    Pawlowski SW; Archbald-Pannone L; Carman RJ; Alcantara-Warren C; Lyerly D; Genheimer CW; Gerding DN; Guerrant RL
    J Hosp Infect; 2009 Oct; 73(2):185-7. PubMed ID: 19709778
    [No Abstract]   [Full Text] [Related]  

  • 3. In vivo selection of moxifloxacin-resistant Clostridium difficile.
    Mena A; Riera E; López-Causapé C; Weber I; Pérez JL; Oliver A
    Antimicrob Agents Chemother; 2012 May; 56(5):2788-9. PubMed ID: 22371889
    [No Abstract]   [Full Text] [Related]  

  • 4. E test susceptibility testing of nosocomial Clostridium difficile isolates against metronidazole, vancomycin, fusidic acid and the novel agents moxifloxacin, gatifloxacin, and linezolid.
    Leroi MJ; Siarakas S; Gottlieb T
    Eur J Clin Microbiol Infect Dis; 2002 Jan; 21(1):72-4. PubMed ID: 11913510
    [No Abstract]   [Full Text] [Related]  

  • 5. Whole-Genome Sequencing Reveals the High Nosocomial Transmission and Antimicrobial Resistance of Clostridioides difficile in a Single Center in China, a Four-Year Retrospective Study.
    Wen X; Shen C; Xia J; Zhong LL; Wu Z; Ahmed MAEE; Long N; Ma F; Zhang G; Wu W; Luo J; Xia Y; Dai M; Zhang L; Liao K; Feng S; Chen C; Chen Y; Luo W; Tian GB
    Microbiol Spectr; 2022 Feb; 10(1):e0132221. PubMed ID: 35019676
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modified multiple-locus variable-number tandem-repeat analysis for rapid identification and typing of Clostridium difficile during institutional outbreaks.
    Broukhanski G; Low DE; Pillai DR
    J Clin Microbiol; 2011 May; 49(5):1983-6. PubMed ID: 21411590
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical and microbiologic characteristics of tcdA-negative variant Clostridium difficile infections.
    Kim J; Pai H; Seo MR; Kang JO
    BMC Infect Dis; 2012 May; 12():109. PubMed ID: 22571633
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Seasonality of Clostridium difficile infections in Southern Germany.
    Reil M; Hensgens MP; Kuijper EJ; Jakobiak T; Gruber H; Kist M; Borgmann S
    Epidemiol Infect; 2012 Oct; 140(10):1787-93. PubMed ID: 22152928
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The tcdA-negative and tcdB-positive Clostridium difficile ST81 clone exhibits a high level of resistance to fluoroquinolones: a multi-centre study in Beijing, China.
    Cheng JW; Liu C; Kudinha T; Xiao M; Fan X; Yang CX; Wei M; Liang GW; Shao DH; Xiong ZJ; Hou X; Yu SY; Wang Y; Yang QW; Su JR; Xu YC
    Int J Antimicrob Agents; 2020 Jul; 56(1):105981. PubMed ID: 32330584
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Toxigenic Clostridium difficile colonization among hospitalised adults; risk factors and impact on survival.
    Behar L; Chadwick D; Dunne A; Jones CI; Proctor C; Rajkumar C; Sharratt P; Stanley P; Whiley A; Wilks M; Llewelyn MJ
    J Infect; 2017 Jul; 75(1):20-25. PubMed ID: 28435086
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clostridium difficile infections in a Canadian tertiary care hospital before and during a regional epidemic associated with the BI/NAP1/027 strain.
    Labbé AC; Poirier L; Maccannell D; Louie T; Savoie M; Béliveau C; Laverdière M; Pépin J
    Antimicrob Agents Chemother; 2008 Sep; 52(9):3180-7. PubMed ID: 18573937
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Outbreak of Clostridium difficile infection in a long-term care facility: association with gatifloxacin use.
    Gaynes R; Rimland D; Killum E; Lowery HK; Johnson TM; Killgore G; Tenover FC
    Clin Infect Dis; 2004 Mar; 38(5):640-5. PubMed ID: 14986246
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clostridium difficile prevalence rates in a large healthcare system stratified according to patient population, age, gender, and specimen consistency.
    Boone JH; Goodykoontz M; Rhodes SJ; Price K; Smith J; Gearhart KN; Carman RJ; Kerkering TM; Wilkins TD; Lyerly DM
    Eur J Clin Microbiol Infect Dis; 2012 Jul; 31(7):1551-9. PubMed ID: 22167256
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Are broad-spectrum fluoroquinolones more likely to cause Clostridium difficile-associated disease?
    Dhalla IA; Mamdani MM; Simor AE; Kopp A; Rochon PA; Juurlink DN
    Antimicrob Agents Chemother; 2006 Sep; 50(9):3216-9. PubMed ID: 16940135
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Emergence of an outbreak-associated Clostridium difficile variant with increased virulence.
    Quesada-Gómez C; López-Ureña D; Acuña-Amador L; Villalobos-Zúñiga M; Du T; Freire R; Guzmán-Verri C; del Mar Gamboa-Coronado M; Lawley TD; Moreno E; Mulvey MR; de Castro Brito GA; Rodríguez-Cavallini E; Rodríguez C; Chaves-Olarte E
    J Clin Microbiol; 2015 Apr; 53(4):1216-26. PubMed ID: 25653402
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular epidemiology of Clostridium difficile strains from nosocomial-acquired infections.
    Corbellini S; Piccinelli G; De Francesco MA; Ravizzola G; Bonfanti C
    Folia Microbiol (Praha); 2014 Mar; 59(2):173-9. PubMed ID: 24081935
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular analysis of the gyrA and gyrB quinolone resistance-determining regions of fluoroquinolone-resistant Clostridium difficile mutants selected in vitro.
    Spigaglia P; Barbanti F; Louie T; Barbut F; Mastrantonio P
    Antimicrob Agents Chemother; 2009 Jun; 53(6):2463-8. PubMed ID: 19364867
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of subinhibitory concentrations of antibiotics on colonization factor expression by moxifloxacin-susceptible and moxifloxacin-resistant Clostridium difficile strains.
    Denève C; Bouttier S; Dupuy B; Barbut F; Collignon A; Janoir C
    Antimicrob Agents Chemother; 2009 Dec; 53(12):5155-62. PubMed ID: 19805572
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Investigation of a cluster of Clostridium difficile infections in a pediatric oncology setting.
    Dantes R; Epson EE; Dominguez SR; Dolan S; Wang F; Hurst A; Parker SK; Johnston H; West K; Anderson L; Rasheed JK; Moulton-Meissner H; Noble-Wang J; Limbago B; Dowell E; Hilden JM; Guh A; Pollack LA; Gould CV
    Am J Infect Control; 2016 Feb; 44(2):138-45. PubMed ID: 26601705
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antimicrobial resistance in
    Imwattana K; Knight DR; Kullin B; Collins DA; Putsathit P; Kiratisin P; Riley TV
    Expert Rev Anti Infect Ther; 2020 Jan; 18(1):17-25. PubMed ID: 31800331
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.